eIF4A Controls Translation of Estrogen Receptor Alpha and Is a Therapeutic Target in Advanced Breast Cancer

Researchers showed that estrogen receptor alpha (ER) translation is eIF4E/cap-independent yet sensitive to inhibitors of the translation initiation factor eIF4A. The combination further lowers ER expression and blocks tumor growth in vitro and in vivo.